← All stocks

UNITED THERAPEUTICS Corp

UTHR Mostly scheduled
CIK 0001082554 #683 in the set updated 21 Sep 2026
Bought (120 mo)
$866.37K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.35B
$1.32M on a plan · $2.34B straight out of an exercise
Sold at will
$11.82M
52 of 5289 sales
Net
−$2.35B
−$10.95M against sales at will

By person

16 insiders · 5,585 transactions
121×

Martine Rothblatt holds 121 times base salary in stock. $187.61M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what Martine Rothblatt last reported holding, valued at $501.60, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ROTHBLATT MARTINE A
Chairperson & CEO
$863.95K (1)
$1.40B (3649) scheduled
−$1.40B
374,024
0.8720%
$187.61M
−4.6%
BENKOWITZ MICHAEL
PRESIDENT AND COO
$350.42M (484) scheduled
−$350.42M
21,623
0.0504%
$10.85M
−83.4%
EDGEMOND JAMES
CFO AND TREASURER
$263.38M (443) scheduled
−$263.38M
18,876
0.0440%
$9.47M
+983.6%
MAHON PAUL A
EVP & GENERAL COUNSEL
$244.91M (499) scheduled
−$244.91M
45,172
0.1053%
$22.66M
−32.4%
SULLIVAN LOUIS W
Director
$17.75M (39) scheduled
−$17.75M
2,983
0.0070%
$1.50M
−0.3%
CAUSEY CHRISTOPHER
Director
$14.53M (38) scheduled
−$14.53M
4,190
0.0098%
$2.10M
+275.8%
Olian Judy D.
Director
$13.41M (25) scheduled
−$13.41M
5,555
0.0130%
$2.79M
PATUSKY CHRISTOPHER
Director
$2.42K (5)
$11.43M (33) scheduled
−$11.42M
3,240
0.0076%
$1.63M
+150.0%
Thompson Tommy G
Director
$10.92M (18) scheduled
−$10.92M
18,270
0.0426%
$9.16M
Giltner Richard
Director
$8.12M (10) scheduled
−$8.12M
21,884
0.0510%
$10.98M
DWEK RAYMOND
Director
$7.24M (15) scheduled
−$7.24M
1,750
0.0041%
$877.80K
KURZWEIL RAY
Director
$7.16M (10) scheduled
−$7.16M
13,320
0.0311%
$6.68M
Mesa Nilda
Director
$1.54M (15)
−$1.54M
5,580
0.0130%
$2.80M
MALCOLM JAN
Director
$653.61K (10) scheduled
−$653.61K
450
0.0010%
$225.72K
MAXWELL LINDA
Director
$456.00K (1) scheduled
−$456.00K
0
0.0000%
$0.00
Klein Katherine J
Director
3,640
0.0085%
$1.83M

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1,203
Amendments (4/A) skipped 25
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 5,221
Sales at will 52
Transactions with no price 0
Shares from compensation/vesting 10,093,534
Sales filed before the plan box existed 31
History held since 2 Sep 2016